You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聯邦制藥(03933.HK)預計上半年盈利約6億元
格隆匯 08-16 18:53

格隆匯8月16日丨聯邦制藥(03933.HK)公佈,預期集團截至2021年6月30日止六個月的淨溢利約為人民幣6億元,而截至2020年6月30日止六個月淨溢利約為人民幣2.03億元。

報吿期內溢利上升主要受惠於:(i)由於中間體產品市場價格持續上漲,期內毛利上升約人民幣2.9億元;(ii)期內並無錄得可換股債券嵌入式衍生工具部分的公平值變動虧損;及(iii)因借貸減少及所有付息可換股債券已於二零二零年內換股,財務成本減少約人民幣9500萬元。

不計算去年同期可換股債券公平值虧損約人民幣2.24億元的影響,截至2021年6月30日止六個月的核心業務的經營溢利比較二零二零年同期上升約40%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account